Skip to main content
Retour
Watch Compare

NANOVIRICIDES, INC.

Qualité des données : 83%
NNVC
NYSE Manufacturing Chemicals
1,16 €
▼ 0,01 € (-0,85%)
6 months return
—
Momentum
Neutral
ROE
-91,18%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-91,18%
En dessous de la moyenne du secteur (-54,68%)
ROIC-72,69%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,43
Interest Coverage-168,54

Valorisation

PE (TTM|NTM)
-2,75 | -3,34
En dessous de la moyenne du secteur (-1,49)
P/B Ratio2,07
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -7,43 M

Price History

Tendances Financières

Objectif de Cours des Analystes

2 analystes
Hold
+460.3%
upside to target
Actuel
1,16 €
Consensus Target
6,50 €
6,00 €
Bas
7,00 €
Haut
Prévisions
P/E Prévisionnel
-3,34
BPA Prévisionnel
-0,35 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,08 € · Rev Est: 0,0
2026-Q1 2026-Q2 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,10 € -0,12 € -0,10 € -0,11 € — —
Estimate -0,08 € -0,08 € -0,18 € -0,08 € -0,08 € -0,08 €
Surprise -25,00% -50,00% +44,44% -37,50% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -91,18% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -8,32 M
ROE -91,18% ROA -80,66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7,43 M
ROIC -72,69% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 4,43
Debt / Equity N/A Current Ratio 4,43
Interest Coverage -168,54 Asset Turnover N/A
Working Capital 4,10 M Tangible Book Value 10,76 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2,75 · EV/EBITDA: N/A
P/E Ratio -2,75 Forward P/E -3,34
P/B Ratio 2,07 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32,46%
Market Cap 22,89 M Enterprise Value 17,74 M

Per Share

EPS: -0,49 · FCF/Share: -0,34
EPS (Diluted TTM) -0,49 Revenue / Share N/A
FCF / Share -0,34 OCF / Share -0,34
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 89,33% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 89,33%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -9,47 M -8,29 M -8,59 M -8,11 M -8,82 M
EPS (Diluted) -0,63 -0,70 -0,74 -0,70 —
Gross Profit — — — — —
Operating Income -9,59 M -8,52 M -8,94 M -8,11 M -8,74 M
EBITDA — — — — —
R&D Expenses 5,55 M 5,44 M 6,39 M 5,78 M 6,11 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 49 808,0 49 808,0 938,0 5 123,0 85 405,0
Income Tax — — — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,82 M 12,82 M 16,90 M 23,49 M 30,26 M
Total Liabilities 1,30 M 1,36 M 2,03 M — —
Shareholders' Equity 7,52 M 11,46 M 14,87 M 23,08 M 29,91 M
Total Debt — — — — —
Cash & Equivalents 1,56 M 4,80 M 8,15 M 14,07 M 20,52 M
Current Assets 1,67 M 4,97 M 8,45 M 14,42 M 20,82 M
Current Liabilities 1,31 M 1,36 M 534 250,0 412 837,0 351 146,0

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -2,8 -1,5
P/B 2,1 1,6
ROE % -91,2 -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,7
D/E — 0,3

ETFs Holding This Stock
BRSIX BRSIX
0,05% weight